Saturday 31 October 2026
Export DOC’s income statement to Excel — free account
Healthpeak Properties, Inc.
DOC Real Estate Reit Healthcare Facilities
Healthpeak Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 4.52% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS grew 60.0%, free cash flow fell 30.5% and total debt rose 11.0%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for five.
19.03
0.09
+0.48%
Follow DOC
Alert me
Healthpeak Properties, Inc. (DOC) revenue by segment, product and region
Where the money comes from and where it goes
| Senior Housing Operating Portfolio | 687 | 32.26% |
|---|---|---|
| Outpatient medical | 446 | 20.96% |
| Senior Housing Triple Net | 423 | 19.87% |
| Lab | 359 | 16.84% |
| Other Non-Reporting Segment | 215 | 10.08% |
| Gross margin | 65.32% | |
| Operating margin | 33.31% | |
| Pre-tax margin | 17.25% |
Revenue by segment $m
| Line | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|
| Senior Housing Operating Portfolio | 687 32.26% | 518 26.71% | 244 14.88% | — | — | — | — | — | — |
| Outpatient medical | 446 20.96% | 415 21.40% | 368 22.49% | 354 16.87% | 335 17.81% | 320 18.91% | 312 25.13% | 309 26.98% | 309 26.96% |
| Senior Housing Triple Net | 423 19.87% | 428 22.07% | 538 32.88% | — | — | — | — | — | — |
| Lab | 359 16.84% | 343 17.68% | 314 19.19% | 297 14.14% | 290 15.41% | 288 17.01% | 277 22.32% | 255 22.24% | 242 21.17% |
| Other Non-Reporting Segment | 215 10.08% | 236 12.14% | 173 10.57% | — | — | — | — | — | — |
| Senior housing | — | — | — | 760 36.21% | 624 33.20% | 519 30.61% | 372 30.03% | 341 29.77% | 349 30.44% |
| Post Acute And Skilled Nursing | — | — | — | 615 29.31% | 550 29.26% | 487 28.75% | 158 12.72% | 119 10.40% | 120 10.52% |
| Hospital | — | — | — | 73 3.48% | 81 4.32% | 80 4.73% | 122 9.80% | 122 10.61% | 125 10.92% |
| Revenue | 2,129 | 1,940 | 1,637 | 2,100 | 1,880 | 1,694 | 1,240 | 1,147 | 1,145 |
Operating figures as reported in each quarter’s results release or filing
| Figure | Quarter | Latest | A year before | Change |
|---|---|---|---|---|
| AFFO a share | Q2 FY2026 | $0.46 | $0.44 | +4.55% |
| FFO a share | Q2 FY2026 | $0.46 | $0.43 | +6.98% |
| Lab new and renewal lease executions | Q3 FY2025 | 339.0K | 465.0K | −27.10% |
| Lab rent mark-to-market on renewals | Q1 FY2026 | 3.50% | 5.00% | — |
| New and renewal lease executions | Q2 FY2026 | 1.6M | 1.5M | +6.67% |
| Outpatient Medical new and renewal lease executions | Q3 FY2025 | 1.2M | 3.0M | −60.00% |
| Outpatient Medical rent mark-to-market on renewals | Q1 FY2026 | 5.40% | 4.00% | — |